Apellis Pharmaceuticals, Inc. (APLS)

20.22 +0.07 (+0.35%) USD  |  NASDAQ  |  Mar 06, 15:47
More

Apellis Pharmaceuticals Net Income (Annual)

Net Income (Annual) Chart

View Net Income (Annual) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Income (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Income (Annual) Range, Past 5 Years

View Net Income (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Income (Annual) Benchmarks

View Net Income (Annual) Benchmarks
Start Trial
Ultragenyx Pharmaceutical, Inc. Upgrade
Amneal Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. Upgrade
BioMarin Pharmaceutical, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade